Avalon Pharma (Middle East Pharmaceutical)
4016.SR
#6845
Rank
NZ$1.05 B
Marketcap
NZ$52.73
Share price
-0.78%
Change (1 day)
-3.94%
Change (1 year)

Avalon Pharma (Middle East Pharmaceutical) (4016.SR) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$89.89 Million

According to Avalon Pharma (Middle East Pharmaceutical)'s latest financial reports the company's total liabilities are NZ$89.89 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Avalon Pharma (Middle East Pharmaceutical) - Total liabilities on balance sheet (from 2023 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$74.93 M21.29%
2023-12-31NZ$61.78 M